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Synthesis of Tetrahydrohexagamavunon-5 (THHGV-5) and 
Tetrahydrohexagamavunone-7 (THHGV-7) were prepared by 
catalytic hydrogenation reaction on Hexagamavunon-5 (HGV-5) 
and Hexagamavunone-7 (HGV-7) by using gas H2 as source of 
hydrogen gas, Pd/C 10 % as metal catalyst and methanol as 
solvent at room temperature. According to previous study, Pd/C 
catalyst is more specific than other metal catalyst to reduce α,β-
unsaturated double bond without reduction of its carbonyl 
functional group. The products were characterized by IR 
Spectroscopy, Gas Chromatography-Mass Spectroscopy (GCMS), 
1D-NMR (1H-NMR and 13C-NMR) and 2D-NMR (1H-13C HMQC) 
Spectroscopy to determine the product structure molecules. 
According to the data of IR, GC-MS, 1H-NMR, 13C-NMR and 1H-13C 
HMQC spectra, the products are THHGV-5 and THHGV-7 as white 
crystalline powders.   
 




Tetrahydrocurcumin (THC) is a main 
metabolite of curcumin. THC has a better 
antioxidant activity than curcumin itself 
(Sugiyama, et al., 1996) and its mechanism has 
been described by Yoysungnoen et al. (2008). 
THC also has some biological activities apart 
from antioxidant such as antidiabetic and 
antihyperlipidemia on diabetic mouse (Murugan 
and Pari, 2007), and anticancer with 
antiangiogenic mechanism (Yoysungneon et al., 
2008). THC itself is normally isolated with 
curcumin from turmeric extracts of 
curcuminoids. THC is easier absorbed in 
gastrointestinal than curcumin (Okada et al., 
2001) and showed that THC is more stable 
than curcumin in physiological buffer pH 7.2 
and blood plasma.  
In our previous publication, there are 
almost fifty analogs curcumin that successfully 
been made (Sardjiman et al., 1997; Sardjiman et 
al., 2003; Sardjiman et al., 2004). These analogs 
have many different biological activities.          
Some of the analogs that we focus on are  
PGV-0, Hexagamavunone-5 (HGV-5) and 
Hexagamavunone-7 (HGV-7). PGV-0 is a 
promising anti-inflammatory agent, HGV-5 has 
a   potent   antioxidant   activity  and  HGV-7 is  
more potent as antibacterial agent against S. 
pneumonia than PGV-0 and curcumin 
(Sardjiman, 2000). 
Some analogs of THC such as 
Tetrahydropentagamavunone-0 (THPGV-0) 
and Tetrahydropentagamavunone-1 (THPGV-
1) have been also successfully synthesized in 
Curcumin Research Center, Faculty of 
Pharmacy, Gadjah Mada University, 
Yogyakarta, Indonesia (Ritmaleni and Simbara, 
2010; Ritmaleni, et al., 2013). Its biological 
activities also have been investigated (Ritmaleni 
et al., 2013). THPGV-0 is made from PGV-0 
and showed better antioxidant activity 
compared to PGV-0 and vitamin E. According 
to this, THHGV-5 and THHGV-7 might have 
biological activities better than HGV-5 and 
HGV-7. This research is aimed to synthesized 
Hexagamavunone-5 (HGV-5) and Hexagama-
vunone-7 (HGV-7).  
 
MATERIAL AND METHODS 
HGV-5 and HGV-7 (Curcumin Research 
Center, Faculty of Pharmacy UGM), Pd/C 10% 
(Aldrich), hydrogen gas (H2) (Samator, 
Yogyakarta), methanol (p.a., Merck), n-hexane 
(p.a., Merck), dichloromethane (p.a., Merck), 
ethyl acetate (p.a., Merck). 
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General procedure 
This synthesis was done based on the 
published method (Ritmaleni and Simbara, 
2010). In round bottom flask, HGV-5 or 
HGV-7 in 5.0mL methanol p.a was added 
Palladium/Carbon (Pd/C) 10% (10 mole %). 
Hydrogen gas (H2) in balloon was blown for 
three hours into the reaction mixture. The 
reaction was an auto indicator reaction; the 
color of reaction mixture is changing from 
yellow to colourless. Then, the mixture was 
filtered and the solvent was evaporated by 
using rotavapor. The products were isolated by 
Flash Column Chromatography and purified by 
recrystallization method. The structure 
elucidation of the targeted product was carried 
out by using Spectroscopy method (IR, GC-
MS, 1D-NMR (1H-NMR and 13C-NMR) and 
2D-NMR (1H-13C HMQC)).  
 
Synthesis of THHGV-5 [TRIVIAL]; 2,6-
bis-(4'-Hydroxy-3',5'-dimethoxybenzil)-
cyclohexanon [IUPAC] 
HGV-5 (250mg; 0.46mmol) in MeOH 
(5mL), Pd/C 10% (49.72mg; 0.46mmol), 
isolated by flash column chromatography 
(Chloroform : Ethyl acetate (5:1), recrystallized 
from ethanol : water (EtOH : H2O = 2:1 v/v), 
THHGV-5 as white crystalline powder; yielded 
23% of THHGV-5; Rf = 0.60 (kloroform : etil 
asetat (5:1 v/v)); mp =139.1 – 139.8°C (EtOH : 
H2O = 2:1 v/v); IR(vmaks, cm-1, KBr), 3410.63 
(OH, bonded); 2935.25 (C-H, stretching, aliphatis); 
1704.33, (C=O, stretching); 1611.02 (C=C, 
stretching, aromatic); 1459.51 (C-H, bending, 
aromatis); 1114.87 (C-O, stretching, aromatic), 
Gas Chromatography (GC): capillary column with 
constantly flow gas; temperature of injection = 
300°C; split injection mode; column flow 0.5 
mL/minute; gas pressure 8.19 psi; time of 
retention (tR) 37.338min; MS (EI-MS, m/z): 
430.2 [M+] (35%), 281 (15%), 207 (34%), 167 
(100%),  122.9 (6%), 96 (6%), 73 (9%), dan 44 
(8%). H-NMR (500 MHz, ppm, CDCl3) : δ 6.37 
(4H, s, H9-Ph x 4), δ 5.36 (2H, s, -OH x 2), δ 
3.85 (4H, s, -OCH3 x 4), δ 3.16 (2H, dd, H7a, J= 
5.2; J= 14.3), δ 2.53 (2H, dddd, H2 and H6, J = 
5.2; J = 5.85; J = 13; J = 13 Hz), δ 2.33 (2H, 
dd, H7b, J = 5.85; J = 14.3 Hz) δ 2.10 (2H, dddd, 
H3a dan H5a, J= 2.6; J= 10.35; J = 13; J = 13.6 
Hz), δ 1.81 (2H, ddd, H4, J= 2.6; J= 5.85; J= 
 
 





  Figure 2. Hydrogenation Reaction of HGV-5 and HGV-7 to be THHGV-5 and  THHGV-7 
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13.6 Hz), δ 1.35 (2H, dddd, H3b and H5b, J= 
5.85; J= 13; J= 13; J= 13.6 Hz). C-NMR (125 
MHz, CDCl3): δ 213.18 (C=O), δ 146.96 (C-
10), δ 133.02 (C-8), δ 131.90 (C-11), δ 105.87 
(C-9), δ 56.44 (C-12), δ 53.63 (C-2 and C-6), δ 





Synthesis of THHGV-7 [TRIVIAL]; 2,6-
bis-(4'-trofluoromethylbenzil)-cyclo-
hexanon [IUPAC] 
HGV-7 (250 mg; 0.6098mmol) in 
MeOH (5mL), Pd/C 10% (64.883mg; 
0.06098mmol), isolated by flash column 
chromatography (n-hexane:dichloromethane 
(C6H14 : CH2Cl2 = 5:3 v/v)), recrystallized from 
ethanol : water (EtOH : H2O= 2:1 v/v), 
THHGV-7 as white crystalline powder; yielded 
19 % of THTGV-7; Rf= 0.72 (n-C6H14 : CH2Cl2 
=5:3 v/v); mp=161.3-162.1°C (EtOH : H2O= 
2:1 v/v); IR (vmax, cm-1, KBr): 3045.81 (C-H, 
stretching, aromatic); 2930.39 (C-H, stretching, 
aliphatic); 1695.53 (C=O, stretching); 1617.88 
(C=C, stretching, aromatic); and 1326.19 (C-F); 
Gas Chromatography (GC): capillary column with 
constantly flow gas; temperature of injection = 
300°C; split injection mode; column flow 0.5mL/min; 
gas pressure 8.19 psi; time of retention (tR) 23.004 
minutes; MS (EI-MS, m/z): 414 [M+] (42%); 
395.1 (25%); 255.1 (68%); 237.0 (38%); 185.0 
(20%); 159.0 (100%); and 109.0 (22%). 1H-
NMR (500 MHz, ppm, CD3OD): δ 7.53 (4H, d, 
J = 7.8 Hz; H10-Ph x 4); δ 7.36 (4H, d, J = 7,8 
Hz; H9-Ph x 4); δ 3.19 (2H, dd, J = 5.85 Hz and 
14.25 Hz; H7a); δ 2.79 (2H, ddd, J = 5.85 Hz; J 
= 12.3 Hz and J = 18.15 Hz; H2 and H6); δ 2.51 
(2H, dd, J = 7.75 Hz and J = 14.25 Hz; H7b); δ 
2.04 (2H, m, H3a and H5a); δ 1.81 – 1.78 (1H, m, 
H4a); δ 1.68 (1H, dddd, J = 3.85 Hz; J = 7.8 Hz; 
12.95 Hz and 16.85 Hz; H4b); δ 1.35-1.39 (2H, 
m, H3b and H5b). 13C-NMR (125 MHz, ppm, 
CD3OD): δ 213.96 (C=O); δ 146.82 (s, C-11); δ 
130.92 (s, C-9); δ 129.7; 129.45; 129.19 and 
128.9 (q, JC,F = 31.25 Hz and JC,F = 62.5 Hz, -
CF3); δ 126.13 (d, C-10); δ 126.10 (d, C-8); δ 
53.62 (s, C-2 and C-6); δ 36.45 (s, C-7); δ 36.34 




RESULT AND DISCUSSION 
Tetrahydrohexagamavunone-5 
(THHGV-5) and Tetrahydrohexagamavu- 
none-7 (THHGV-7) were synthesized by using 
catalytic hydrogenation reaction on Hexagama-
vunone-5 (HGV-5) and Hexagamavunone-7 
(HGV-7) subsequently. Both reactions were 
catalyzed by Palladium/Carbon (Pd/C) 10% as 
metal catalyst. Palladium/Carbon (Pd/C) 10% 
is usually used in this kind of reaction because 
this catalyst could make the hydrogenation be 
done at room temperature and certainly 
accelerate the rate of reaction. According to 
previous study, Pd/C catalyst is more specific 
than other metal catalyst to reduce α,β-
unsaturated double bond without reduction of 
its carbonyl functional group (Solomons, 1990).  
The hydrogenation on HGV-5 and 
HGV-7 removed their chromophores 
(conjugation double bond) which appeared as 
yellow color and they were transformed into 
α,β-unsaturated ketone which appeared as white 
color compounds, THHGV-5 (23%) and 
THHGV-7 (19%), respectively. Low yields 
were obtained due to the side products 
formation. In this kind of reactions, around 
four side products were present in the reaction 
mixture. This type of structure make the 
reduction possible not only on the α,β-
unsaturated ketone but also reduce the keton to 
alcohol and alkane (Ritmaleni et al., 2013). 
 
Structure elucidation of THHGV-7 
[TRIVIAL]; 2,6-bis-(4'-trofluoromethyl-
benzil)-cyclohexanone [IUPAC] 
Hydrogenation means hydrogenation 
addition. On this reaction the hydrogen was 
added to the α,β-unsaturated ketone only the 
double bond that received the hydrogen. 
According to the IR spectra, no peak indicated 
the double bond functional group of α,β-
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unsaturated ketone, only aliphatic C-H bond at 
2935.2cm-1 can be seen while the C=O bond 
of carbonyl functional group was still can be 
seen at 1704.3cm-1. On the H-NMR spectra, 
there is no alkene peak obtained, there are one 
peak appeared at 3.16ppm and one peak more 
appeared at 2.33ppm. These both are peaks of 
proton of alkane on benzyl functional group. 
Another proton that can indicate that addition 
of hydrogen has been successfully added to the 
double bond is the proton that appeared on 
2.53 ppm as doublet of doublet of doublet of doublet 
and this is corresponding to proton on alpha 
position of cyclohexanone. Also no carbon 
alkene was found on the C-NMR spectra. And 
the other spectra have strongly recommended 
that the product is THHGV-5.  
 




Based on the data of GC chromatogram 
and MS spectra, the level of THHGV-7’s purity 
is about 97.02 %. Furthermore, the structure of 
THHGV-7 was characterized by IR, 1D-NMR 
(1H-NMR, 13C-NMR), and 2D-NMR (1H-13C 
HMQC) Spectroscopy. 
THHGV-7 and HGV-7 only differ in 
α,β-unsaturated carbonyl. IR spectra shown that 
no double bond of α,β-unsaturated ketone was 
obtained but the C=O stretching is still there 
where a peak at 1695.53 was obtained. 1H-
NMR spectra of THHGV-7 showed a peak 
signal at 2.79 ppm (-CH-α-carbonil; methyne 
group), whereas it was undetected on HGV-7’s. 
Furthermore, 1H-NMR spectra of THHGV-7 
showed the existence of –CH2-β-carbonyl 
(methylene group) at 3.19 ppm (H7a); and 2.51 
ppm (H7b). 13C-NMR spectra showed chemical 
shift of –C-α,β-carbonyl on THHGV-7 (53.62 
and 36.45 ppm). At last, analyzing THHGV-7 
by 1H-13C HMBC and HMQC Spectroscopy 
were carried out. These methods analyze the 
data correlation between atom H and atom C 
spectra of the product that coupling each other. 
According to that there were some data 
correlation between atom H and atom C, such 
as cross peak diagonal between atom H2 at δ 
2.79 ppm and atom C2 at δ 53.62 ppm. These 
data strongly recommend that the product is 
THHGV-7. 
CONCLUSION 
 THHGV-5  and THHGV-7 can be 
synthesized by catalytic hydrogenation reaction 
on Hexagamavunone-5 (HGV-5) and 
Hexagamavunone-7 (HGV-7) respectively by 
using hydrogen gas as hydrogen source, Pd/C 
10 % as metal catalyst and methanol as solvent 
at room temperature with 23 and 19 % yields. 
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